Search

everythinglearnresearchcommunity

for

Search:↓

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Bitter melon extract may help prevent hair loss and can be used in cosmetic products.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Early treatment of PCOS in teens is crucial to prevent long-term health issues like diabetes and heart disease.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Bald men may have a lower risk of testicular cancer.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Researchers found a gene in hamsters that responds to male hormones and may be indirectly controlled by them.

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.

Blocking androgen activity in newborn rats affects body weight and appetite-related hormones differently in males and females.

Androgen affects oil production and hair growth in the skin.

Testosterone may slow down wound healing and increase inflammation.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

New steroids were effective in blocking male hormone receptors in hamster prostates.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Men with androgenetic alopecia have oilier and less hydrated scalps, especially in sensitive areas.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Finasteride helps treat hair loss by blocking enzyme activity.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.